about
Liver growth factor as a tissue regenerating factor in neurodegenerative diseasesEffects of intravenous administration of human umbilical cord blood stem cells in 3-acetylpyridine-lesioned ratsNeuroprotective role of liver growth factor "LGF" in an experimental model of cerebellar ataxiaNeuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's diseaseMobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factorDriving neural stem cells towards a desired phenotype.Applications of human umbilical cord blood cells in central nervous system regeneration.Neuroprotective diets for stroke.Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich's Ataxia Transgenic Mice.Optimal excitation and emission wavelengths to analyze amino acids and optimize neurotransmitters quantification using precolumn OPA-derivatization by HPLC.Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.High potassium induces taurine release by osmosensitive and osmoresistant mechanisms in the rat hippocampus in vivo.Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats.Kainic acid triggers oligodendrocyte precursor cell proliferation and neuronal differentiation from striatal neural stem cells.TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal ModelsPLA2G6 -Associated Neurodegeneration: Report of a Novel Mutation in Two Siblings with Strikingly Different Clinical Presentation.Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's diseaseNew Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke TreatmentCharacterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic StrokeNeuroprotective Effects of Diets Containing Olive Oil and DHA/EPA in a Mouse Model of Cerebral IschemiaLiver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease
P50
Q26861673-51976856-DE89-403B-B2AD-EE10C4411B26Q28390509-4A5F90D5-C6FC-418C-BB7D-46731DF0420EQ28397547-823A581D-0B02-4591-9193-4CFE437D046BQ34826133-065A760E-F552-4AE6-93D7-736BA1FEA4CCQ37174009-54775115-948D-42FE-9FAA-D569C9F8A12EQ37347504-B2E2C953-D40E-4A98-844C-A9ECBFB9565DQ37609447-7F790F02-985E-47A3-A50A-B0B808C70626Q39119877-45EC18A9-AF73-4455-B443-5AF09291D5EDQ39935809-65127470-0114-4309-8B69-CACCA3DDE5FCQ40020310-23493524-91DE-4DB9-85F1-DBECB3F1F73CQ46332657-DC349D75-DDD3-43E3-87FC-EF256B07A12AQ46443571-8FF74295-D11C-4ABC-947F-6EF53137CE53Q46847882-F9C89E01-5B48-4D82-91A3-4B7A21125C44Q48251410-F4D551A8-4217-4C04-B3D0-1FCFF8433C67Q57173182-C456737B-6D25-4A8E-8A1B-4C69842FFE5BQ64949196-0FEC8250-894E-4D53-9EEC-B93026054977Q83055130-B5DF4EBC-4D0F-4980-8067-41D6796858AEQ91331438-DEF6FEA8-2A50-4594-8378-04F7B20A4734Q91540391-AB2A4770-77A5-406A-BCF5-A9D245E35FF6Q92164552-6170634E-C87C-4C4C-B995-D56C7BE8EB8EQ95829514-C652E242-85AA-48CE-8DBF-855B47995558
P50
description
researcher ORCID ID = 0000-0002-6357-105X
@en
wetenschapper
@nl
name
Rafael Gonzalo-Gobernado
@ast
Rafael Gonzalo-Gobernado
@en
Rafael Gonzalo-Gobernado
@es
Rafael Gonzalo-Gobernado
@nl
type
label
Rafael Gonzalo-Gobernado
@ast
Rafael Gonzalo-Gobernado
@en
Rafael Gonzalo-Gobernado
@es
Rafael Gonzalo-Gobernado
@nl
altLabel
Rafael Gonzalo Gobernado
@en
prefLabel
Rafael Gonzalo-Gobernado
@ast
Rafael Gonzalo-Gobernado
@en
Rafael Gonzalo-Gobernado
@es
Rafael Gonzalo-Gobernado
@nl
P1053
F-2675-2016
P106
P1153
12788756400
P21
P31
P496
0000-0002-6357-105X